The Effect of PAP on ISSHL Comorbided With OSA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Effect of PAP on ISSHL Comorbided With OSA — Stella

Home/Sudden Hearing Loss/

View on ClinicalTrials.gov

Recruiting

Back to Sudden Hearing Loss trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Beijing Tsinhgua Changgung Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment target

~102 participants

Started

November 2019

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated December 2019

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.